GET DAILY SIGNALSCommunity Healthcare Trust (CHCT) Shows Measured Progress in Q3 2026 Results
Key Takeaways
- Community Healthcare Trust (CHCT) reported third quarter 2026 net income of approximately $3.1 million, or $0.09 per diluted common share.
- Funds from operations (FFO), a key profitability measure for real estate investment trusts, came in at $0.54 per diluted share, up 8.0% year over year.
- Adjusted funds from operations (AFFO) reached $0.58 per diluted share, up 3.6% from the prior-year quarter, while total revenue grew 4% sequentially.
- Leased occupancy improved to 90.1% from 89.8% in the prior quarter, and the company completed $32.3 million in property dispositions as part of its capital recycling strategy.
- The board declared a quarterly dividend of $0.33 per share, unchanged from the prior quarter, payable on November 25, 2026.
Putting the Earnings in Context
Community Healthcare Trust Incorporated is a real estate investment trust (REIT) that owns income-producing outpatient healthcare properties leased to hospitals, physicians, and other providers across the United States. Its third quarter 2026 results arrive during a period of deliberate repositioning, as management executes the strategic plan first announced in August 2026. For investors, this report matters because it measures whether the company is translating that strategy into higher occupancy, controlled costs, and improved cash flow. The year-over-year gains in FFO and AFFO, combined with the fourth consecutive stable dividend, offer a clearer read on the durability of the company's earnings power and its ability to fund future growth. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Breaking Down the Reported Results
For the three months ended September 30, 2026, Community Healthcare Trust reported net income of approximately $3.1 million, or $0.09 per diluted common share. Total revenue reached $32.4 million, up $1.2 million, or 4%, from the second quarter of 2026, driven primarily by higher rental income. On the metrics most closely followed by REIT investors, FFO totaled $0.54 per diluted share, while AFFO came in at $0.58 per diluted share, reflecting 8.0% and 3.6% year-over-year improvements, respectively.
Operationally, leased occupancy improved to 90.1% from 89.8% in the prior quarter, and general and administrative expenses declined by $0.7 million, or 14.3%. The quarter also included a $0.7 million loss on the sale of one property and continued progress on a $99 million pipeline of four properties under definitive purchase agreements, with expected returns of 9.1% to 9.75%. Notably, the geriatric behavioral hospital tenant paid approximately $0.5 million in rent, up from about $0.3 million in the prior quarter. From what I see, these details point to incremental operational improvements worth tracking closely.
Market Reaction and Investor Sentiment
Community Healthcare Trust's stock has faced volatility in recent quarters as investors weighed the company's turnaround efforts against broader pressures in the healthcare REIT space, including higher interest expenses and tenant transition risk. The third quarter results provided several constructive signals — rising occupancy, expanding FFO, and controlled costs — that may support sentiment, although lingering uncertainty around the pending sale of the behavioral hospital portfolio and the timing of new acquisitions continue to temper enthusiasm. The stock's reaction will likely hinge on whether investors view the sequential improvement as evidence that the strategic plan is translating into sustainable earnings growth.
Forward Outlook and Key Factors to Monitor
Looking ahead, investors should watch how Community Healthcare Trust funds and closes its signed acquisition pipeline. The company expects to close on the first of its four contracted properties in the fourth quarter of 2026, a second in the first quarter of 2027, and the remaining two between mid-2027 and early 2028, with projected returns of roughly 9.1% to 9.75%.
Capital recycling remains central to the strategy. Following the quarter's end, the company sold two additional properties for net proceeds of approximately $31.5 million, which are expected to fund acquisitions through a like-kind exchange and general corporate purposes. These dispositions could temporarily pressure revenue until replacement acquisitions stabilize.
Occupancy trends and rent collection from the behavioral hospital tenant are also worth monitoring. While that tenant's rent payments increased, the sale of its business to a behavioral healthcare provider remains in due diligence, and the timing of a closing is uncertain. Finally, investors should track interest expense, which has risen alongside the company's debt levels and the expiration of prior interest rate hedges, as a key factor influencing future FFO and dividend coverage. I’m watching this closely as it could shape near-term performance.
Exploring AI Tools in My Research Process
In my analysis of healthcare REITs like CHCT, I frequently rely on Tickeron’s AI tools to cross-check patterns and peer comparisons. One resource I find particularly useful is the AI Screener, which helps surface stocks matching specific criteria such as occupancy trends or FFO growth. It streamlines the process of identifying comparable opportunities without replacing my own due diligence.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CHCT's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for CHCT turned positive on October 27, 2026. Looking at past instances where CHCT's MACD turned positive, the stock continued to rise in 30 of 46 cases over the following month. The odds of a continued upward trend are 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CHCT's RSI Oscillator exited the oversold zone, 22 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on CHCT as a result. In 46 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.
Following a +1.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHCT advanced for three days, in 159 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 52%.
CHCT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHCT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
The Aroon Indicator for CHCT entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 57 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.913) is normal, around the industry mean (3.125). P/E Ratio (19.701) is within average values for comparable stocks, (28.561). Projected Growth (PEG Ratio) (1.050) is also within normal values, averaging (1.649). CHCT has a moderately high Dividend Yield (0.100) as compared to the industry average of (0.049). P/S Ratio (3.170) is also within normal values, averaging (6.013).
The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. CHCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a healthcare real estate investment trust
Industry PublishingBooksMagazines
Advertisement